Literature DB >> 3280130

Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.

R Cherniak1, R G Jones, E Reiss.   

Abstract

A series of polysaccharides was derived by physical and chemical methods from an antigenic, O-acetyl-containing, glucuronoxylomannan (GXM), isolated from the growth medium of Cryptococcus neoformans (CDC B2550) serotype A-variant having composition ratios of Man:Xyl:GlcA:OAc = 10:4:3:6. 13C-N.m.r. spectra of derivatives provided new structural evidence for GXM. Treatment of GXM with Li in ethylenediamine gave a xylomannan (XM, with Man:Xyl = 5:2). Smith degradation of XM gave a mannan (M). Ultrasonic treatment of GXM gave GXM-sonicated (GXMS). Treatment of GXM with 3-(3-dimethylaminopropyl)-1-ethylcarbodiimide.HCl and then with NaBH4 gave reduced GXMS (RGXMS), or with aq. trifluoroacetic acid gave partially acid-hydrolyzed GXMS. Periodate oxidation of GXM and NaBH4 reduction of the product gave a polyalcohol-mannan (PM). Treatment of GXMS, RGXMS, and PM with NH4OH at pH 11 gave the respective O-deacetylated analogs. Comparison among the 13C-n.m.r. spectra of GXM, the various derivatives, and reference monosaccharides allowed the following conclusions: M is (1----3)-alpha-D-mannopyranan; XM consists of the M backbone with 91% of the Xyl on nonadjacent Man residues as 2-O-beta-D-Xylp substituents and with 9% as 4-O-D-Xylp substituents on other Man residues. GXM consists of the XM structure, but with non-D-xylosylated Man residues substituted with 2-O-beta-D-GlcpA substituents and with 6-O-acetyl groups distributed approximately equally on Man residues that have other substituents and those that have none. The molecular mechanics program MM2 was used to estimate the relative energies of anomeric orientations of the typical glycosidic linkage in M. The results suggest that 6'-OH----O-2 H-bonding is significant in the minimal-energy orientation of M, with phi = -36 degrees and psi = 51 degrees, and that two other glycosidic orientations may be important in the 2-O- or 6-O-substituted derivatives of M.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280130     DOI: 10.1016/s0008-6215(00)90846-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  20 in total

1.  Localization of mannoprotein in Cryptococcus neoformans.

Authors:  S E Vartivarian; G H Reyes; E S Jacobson; P G James; R Cherniak; V R Mumaw; M J Tingler
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

2.  Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.

Authors:  B J Young; T R Kozel
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

3.  Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.

Authors:  C Spiropulu; R A Eppard; E Otteson; T R Kozel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans.

Authors:  Radames J B Cordero; Bruno Pontes; Allan J Guimarães; Luis R Martinez; Johanna Rivera; Bettina C Fries; Leonardo Nimrichter; Marcio L Rodrigues; Nathan B Viana; Arturo Casadevall
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

5.  Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen.

Authors:  L Millon; T Barale; M C Julliot; J Martinez; G Mantion
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

6.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 7.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 8.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

9.  Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.

Authors:  Christian Heiss; Michael L Skowyra; Hong Liu; J Stacey Klutts; Zhirui Wang; Matthew Williams; Deepa Srikanta; Stephen M Beverley; Parastoo Azadi; Tamara L Doering
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

10.  The still obscure attributes of cryptococcal glucuronoxylomannan.

Authors:  Marcio L Rodrigues; Fernanda L Fonseca; Susana Frases; Arturo Casadevall; Leonardo Nimrichter
Journal:  Med Mycol       Date:  2009-12       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.